Evidence map›Paper›PMID 24809668›Full record

ArticlePLoS genetics2014

Hyperactivated Wnt signaling induces synthetic lethal interaction with Rb inactivation by elevating TORC1 activities.

Tianyi Zhang, Yang Liao, Fu-Ning Hsu, Robin Zhang, Jennifer S Searle, Xun Pei, Xuan Li, Hyung Don Ryoo, Jun-Yuan Ji, Wei Du

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Reversal of hyperactive Wnt signaling-dependent adipocyte defects by peptide boronic acids.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Tianyi ZhangBen May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America.
Yang LiaoBen May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America.
Fu-Ning HsuDepartment of Molecular and Cellular Medicine, College of Medicine, Texas A&M Health Science Center, College Station, Texas, United States of America.
Robin ZhangBen May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America.
Jennifer S SearleBen May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America.
Xun PeiBen May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America.
Xuan LiBen May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America.
Hyung Don RyooDepartment of Cell Biology, New York University School of Medicine, New York, New York, United States of America.
Jun-Yuan JiDepartment of Molecular and Cellular Medicine, College of Medicine, Texas A&M Health Science Center, College Station, Texas, United States of America.
Wei DuBen May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America.
University of Chicago · USTexas A&M Health Science Center · USNew York University · US

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Unfolded Protein Response in Eye Development and DiseaseR01EY020866 · NEI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HYUNG D RYOO · 2010 to 2026
$6.9M
Center for Herbal Research on Colorectal CancerP01AT004418 · NCCIH · UNIVERSITY OF CHICAGO · PI YUAN, CHUN-SU · 2008 to 2012
$5.9M
Control of Cell Proliferation and Differentiation in the Developing RetinaR01GM074197 · NIGMS · UNIVERSITY OF CHICAGO · PI DU, WEI · 2006 to 2013
$2.4M
A novel approach to target Rb mutant cancersR01CA149275 · NCI · UNIVERSITY OF CHICAGO · PI DU, WEI · 2011 to 2015
$1.6M
Context-specific Functions of CDK8R01DK095013 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI JI, JUN-YUAN · 2013 to 2017
$1.5M
NCATS NIH HHS UL1 TR000430NCCIH NIH HHS AT004418NCCIH NIH HHS P01 AT004418NCI NIH HHS CA149275NCI NIH HHS R01 CA149275NEI NIH HHS R01 EY020866NIDDK NIH HHS R01 DK095013NIGMS NIH HHS GM074197NIGMS NIH HHS R01 GM074197
6 · The paper itself

Abstract

Inactivation of the Rb tumor suppressor can lead to increased cell proliferation or cell death depending on specific cellular context. Therefore, identification of the interacting pathways that modulate the effect of Rb loss will provide novel insights into the roles of Rb in cancer development and promote new therapeutic strategies. Here, we identify a novel synthetic lethal interaction between Rb inactivation and deregulated Wg/Wnt signaling through unbiased genetic screens. We show that a weak allele of axin, which deregulates Wg signaling and increases cell proliferation without obvious effects on cell fate specification, significantly alters metabolic gene expression, causes hypersensitivity to metabolic stress induced by fasting, and induces synergistic apoptosis with mutation of fly Rb ortholog, rbf. Furthermore, hyperactivation of Wg signaling by other components of the Wg pathway also induces synergistic apoptosis with rbf. We show that hyperactivated Wg signaling significantly increases TORC1 activity and induces excessive energy stress with rbf mutation. Inhibition of TORC1 activity significantly suppressed synergistic cell death induced by hyperactivated Wg signaling and rbf inactivation, which is correlated with decreased energy stress and decreased induction of apoptotic regulator expression. Finally the synthetic lethality between Rb and deregulated Wnt signaling is conserved in mammalian cells and that inactivation of Rb and APC induces synergistic cell death through a similar mechanism. These results suggest that elevated TORC1 activity and metabolic stress underpin the evolutionarily conserved synthetic lethal interaction between hyperactivated Wnt signaling and inactivated Rb tumor suppressor.

Indexed as

Genes, RetinoblastomaSignal TransductionAnimalsApoptosisBase SequenceDNA PrimersDrosophilaGenes, LethalMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPolymerase Chain ReactionTOR Serine-Threonine KinasesWnt ProteinsDNA PrimersMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesTOR Serine-Threonine KinasesWnt Proteins

Identifiers

PMID24809668
PMCPMC4014429
OpenAlexW2017558556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.